HPV vaccines and autoimmune diseases

Journal of Internal Medicine

Volumn 272, Issue 1, 2012, Pages 98-

  Shoenfeld, Y ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

AUTOIMMUNE DISEASE; HUMAN; LETTER; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; VACCINATION;

AUTOIMMUNE DISEASES; FEMALE; HUMANS; PAPILLOMAVIRUS VACCINES;

EID: 84862690127     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2012.02537.x     Document Type: Letter

References (8)

1. Chao C, Klein NP, Velicer CM et al. Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine. J Intern Med 2011; 271: 193-203.
2. Haug C. The risk and benefits of HPV vaccination. JAMA 2009; 302: 795-6.
3. Shoenfeld Y, Cervera R, Gershwin ME. Diagnostic Criteria in Autoimmune Diseases. Tolowa, NJ, USA: Humana Press, Springer Science, LLC, 2008; 1-593.
4. Shoenfeld Y, Agmon-Levin N. 'ASIA'- autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun 2011; 36: 4-8.
5. Herman MA, Jick SS, Olek MJ, Jick H. Recombinant hepatitis B vaccine and the risk of multiple sclerosis. Neurology 2004; 63: 838-42.
6. Slade BA, Leidel L, Vellozzi C et al. Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. JAMA 2009; 7: 750-7.
7. Mikaeloff Y, Caridade G, Suissa S, Tardieu M. Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood. Neurology 2009; 72: 873-80.
8. Special issue of LUPUS 2012; 21(2) (February) dedicated to the ASIA syndrome.